ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,947, issued on July 7, was assigned to Cytosinlab Therapeutics Co. Ltd. (Shanghai).
"Pyrido-pyrazinyl compounds for treating acute myeloid leukemia" was invented by Haiping Wu (Shanghai), Meng Wang (Shanghai), Yuan Mi (Shanghai), Xingnian Fu (Shanghai), Hui Shi (Shanghai) and Jiannan Guo (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compounds having kinase inhibitory activity. Specifically, the present invention provides compounds having a structure represented by the following formula (II). The compound of the present invention has good inhibitory activity for a variety of kinases (e.g. ALK, AXL, EGFR, and F...